These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 8841156
21. Cost-effectiveness of telavancin versus vancomycin for treatment of complicated skin and skin structure infections. Laohavaleeson S, Barriere SL, Nicolau DP, Kuti JL. Pharmacotherapy; 2008 Dec; 28(12):1471-82. PubMed ID: 19025428 [Abstract] [Full Text] [Related]
22. Mild nephrotoxicity associated with vancomycin use. Downs NJ, Neihart RE, Dolezal JM, Hodges GR. Arch Intern Med; 1989 Aug; 149(8):1777-81. PubMed ID: 2764651 [Abstract] [Full Text] [Related]
23. A retrospective analysis to estimate target trough concentration of vancomycin for febrile neutropenia in patients with hematological malignancy. Suzuki Y, Tokimatsu I, Morinaga Y, Sato Y, Takano K, Kohno K, Ogata M, Hiramatsu K, Itoh H, Kadota J. Clin Chim Acta; 2015 Feb 02; 440():183-7. PubMed ID: 25476135 [Abstract] [Full Text] [Related]
24. Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes. Davis SL, McKinnon PS, Hall LM, Delgado G, Rose W, Wilson RF, Rybak MJ. Pharmacotherapy; 2007 Dec 02; 27(12):1611-8. PubMed ID: 18041881 [Abstract] [Full Text] [Related]
25. [Glycopeptides and the newborn infant's kidney]. Fanos V, Benini D, Vinco S, Pizzini C, Khoory BJ. Pediatr Med Chir; 1997 Dec 02; 19(4):259-62. PubMed ID: 9508651 [Abstract] [Full Text] [Related]
30. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?]. Carvalho A, Fonseca C, Falcão F, Pereira TA, Freitas O, Parrinha A, Costa M, Rodrigues MJ, Ceia F, Luís AS. Acta Med Port; 1996 Dec 02; 9(7-9):187-95. PubMed ID: 9005695 [Abstract] [Full Text] [Related]
31. Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections. Patanwala AE, Erstad BL, Nix DE. Curr Med Res Opin; 2007 Jan 02; 23(1):185-93. PubMed ID: 17257479 [Abstract] [Full Text] [Related]
32. [Evaluation of the incidence of nephrotoxicity associated with the use of aminoglycosides in patients with extrahepatic biliary obstruction]. Márquez E, Lucena MI, Andrade RJ, González-Correa JA, Clavijo E, Lazo MD, Sánchez de la Cuesta F. Rev Clin Esp; 1992 Jun 02; 191(2):76-9. PubMed ID: 1502393 [Abstract] [Full Text] [Related]
35. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions? Müller MJ, Dragicevic A, Fric M, Gaertner I, Grasmäder K, Härtter S, Hermann E, Kuss HJ, Laux G, Oehl W, Rao ML, Rollmann N, Weigmann H, Weber-Labonte M, Hiemke C. Pharmacopsychiatry; 2003 May 02; 36(3):98-104. PubMed ID: 12806567 [Abstract] [Full Text] [Related]
36. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study. Matson KL, Shaffer CL, Beck GL, Simonsen KA. Pharmacotherapy; 2015 Mar 02; 35(3):337-43. PubMed ID: 25756622 [Abstract] [Full Text] [Related]